Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -13.277\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CC(=O)N=c1c(C#N)cc2c(=O)n3cccc(C)c3nc2n1CCCOC(C)C
b. O=C(NCCS(=O)(=O)NCc1ccc(Cl)cc1)c1ccccc1
Answer: a. CC(=O)N=c1c(C#N)cc2c(=O)n3cccc(C)c3nc2n1CCCOC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)N=c1c(C#N)cc2c(=O)n3cccc(C)c3nc2n1CCCOC(C)C
CC(=O)N=c1c(C#N)cc2c(=O)n3cccc(C)c3nc2n1CCCOC(C)C
N-[5-cyano-11-methyl-2-oxo-7-(3-propan-2-yloxypropyl)-1,7,9-triazatricyclo[8.4.0.03,8]tetradeca-3(8),4,9,11,13-pentaen-6-ylidene]acetamide